Cholangioscopy Using Narrow Band Imaging (NBI) in Patients With Primary Sclerosing Cholangitis (PSC) Undergoing ERCP.
N/A
18 Years
75 Years
18 Years
75 Years
Not Enrolling
Both
Primary Sclerosing Cholangitis
Both
Primary Sclerosing Cholangitis
Trial Information
Cholangioscopy Using Narrow Band Imaging (NBI) in Patients With Primary Sclerosing Cholangitis (PSC) Undergoing ERCP.
Inclusion Criteria:
- Patients with PSC presenting for ERCP where tissue sampling is indicated
- Adults age 18 to 75 years old
- Able to give informed written consent
- Either male or female
Exclusion Criteria:
- PSC with acute cholangitis
- Patients with acute or chronic, debilitating cardiopulmonary disease who are unable
to safely undergo prolonged conscious sedation
- Patients with a prior history of liver transplant
- Prisoners
- Unable or unwilling to give informed consents
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Outcome Measure:
Cholangioscopy with NBI will enhance the ability to identify sites of potential dysplasia or malignancy in patients with PSC and will be more sensitive in identifying dysplasia than ERCP with biliary brushing and fluoroscopy-guided forceps biopsy.
Outcome Time Frame:
One year
Safety Issue:
No
Authority:
United States: Institutional Review Board
Study ID:
08-006221
NCT ID:
NCT00951327
Start Date:
November 2008
Completion Date:
August 2010
Related Keywords:
- Primary Sclerosing Cholangitis
- Primary sclerosing cholangitis
- Cholangitis
- Cholangitis, Sclerosing
Name | Location |
|---|---|
| Mayo Clinic Rochester | Rochester, Minnesota 55905 |
